600612:SSELao Feng Xiang Co., Ltd. Class A Analysis
Data as of 2026-08-31 - not real-time
CN¥33.06
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Lao Feng Xiang Co., Ltd. is priced at ¥33.06, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 7.2%. Relative strength is 40.1 — neutral — and the MACD signal is bearish. The recent range runs from support at ¥32.25 up to resistance at ¥36.90.
The shares look undervalued at 13.8 times earnings, though no sector average was available for comparison. Consensus targets land 38.3% above where the shares trade now. Revenue is contracting at 21.6% on a 3.4% profit margin. The 4.74% dividend yield looks stretched against payout coverage.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 32.5%, a beta of 0.10 and a maximum drawdown of 42.6%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
The shares look undervalued at 13.8 times earnings, though no sector average was available for comparison. Consensus targets land 38.3% above where the shares trade now. Revenue is contracting at 21.6% on a 3.4% profit margin. The 4.74% dividend yield looks stretched against payout coverage.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 32.5%, a beta of 0.10 and a maximum drawdown of 42.6%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
Investing1yLao Feng Xiang Co Ltd AYou can read more about Gross Profit here.Investing11monLao Feng Xiang Co Ltd AClick the link below to download a spreadsheet with an example Revenue calculation...Find the latest Lao Feng Xiang Co., Ltd. 600612.SS stock quote, history, news and other vital information to help you...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 40.34
- MACD momentum is negative
- 30-day price change of -7.2%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Dividend yield of 4.74% looks stretched against payout coverage
- Trading below the 200-day average of 40.34
- Analyst targets imply +38.3% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Dividend yield of 4.74% looks stretched against payout coverage
- Analyst targets imply +38.3% versus the current price
- Revenue contracting at -21.6%
Key Metrics & Analysis
Financial Health
Revenue Growth-21.60%
Profit Margin3.44%
P/E Ratio13.8
ROE13.51%
ROA6.76%
Debt/Equity41.10
P/B Ratio1.3
Op. Cash FlowCN¥65.0M
Free Cash FlowCN¥-1207701760
Technical Analysis
TrendNeutral
RSI40.1
SupportCN¥32.25
ResistanceCN¥36.90
MA 20CN¥34.67
MA 50CN¥34.45
MA 200CN¥40.34
MACDBearish
VolumeStable
Fear & Greed Index94.29
Valuation
Fair ValueCN¥9.81
Target PriceCN¥45.71
Upside/Downside38.25%
GradeUndervalued
TypeValue
Dividend Yield4.74%
Risk Assessment
Beta0.10
Volatility32.45%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.